A5007862725- Venous Thromboembolism Diagnosis and Management
- Platelet Disorders and Treatments
- Lymphoma Diagnosis and Treatment
- Antiplatelet Therapy and Cardiovascular Diseases
- Viral-associated cancers and disorders
- Lung Cancer Diagnosis and Treatment
- COVID-19 and healthcare impacts
- Multiple Myeloma Research and Treatments
- Polyomavirus and related diseases
- Drug-Induced Hepatotoxicity and Protection
- Medical Imaging Techniques and Applications
- Lung Cancer Treatments and Mutations
- Global Cancer Incidence and Screening
- Pharmacological Effects and Toxicity Studies
- Hematopoietic Stem Cell Transplantation
- Healthcare cost, quality, practices
- MRI in cancer diagnosis
- CNS Lymphoma Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Heparin-Induced Thrombocytopenia and Thrombosis
University of Kansas Medical Center
2017-2022
University Medical Center
2021
von Willebrand disease (VWD) disproportionately affects women because of the potential for heavy menstrual bleeding (HMB), delivery complications, and postpartum hemorrhage (PPH). To systematically synthesize evidence regarding first-line management HMB, treatment requiring or desiring neuraxial analgesia, PPH. We searched Medline EMBASE through October 2019 randomized trials, comparative observational studies, case series comparing effects desmopressin, hormonal therapy, tranexamic acid...
The COVID-19 pandemic has had a distinct spatiotemporal pattern in the United States. Patients with cancer are at higher risk of severe complications from COVID-19, but it is not well known whether outcomes this patient population were associated geography. To quantify variation among patients cancer. This registry-based retrospective cohort study included historical diagnosis invasive malignant neoplasm and laboratory-confirmed SARS-CoV-2 infection between March November 2020. Data...
Abstract Background Despite advances in treatment, multiple myeloma (MM) remains incurable and results significant morbidity mortality. Further research investigating where MM patients die characterization of end-of-life hospitalizations is needed. Methods We utilized the National Inpatient Sample (NIS) to explore hospitalization burden at end their lives. Results The percent dying hospital as a overall deaths ranged from 54% 2002 41.4% 2017 ( p < 0.01). Blood transfusions were received...
Surveillance scans after autologous stem cell transplant (auto-HCT) for patients with relapsed/refractory (RR) diffuse large B Cell lymphoma (DLBCL) have no proven survival benefit. We studied differences among RR DLBCL post auto-HCT whose recurrences were detected clinically versus routine surveillance imaging. Among the 139 that underwent from 2000 to 2014 at our institution, 37 relapsed: 21 clinical and 16 radiological. The median time progression was 167 days cohort 565 radiological (p =...
<b><i>Background:</i></b> Surveillance scans performed after autologous stem cell transplant (auto-HCT) for patients with Hodgkin disease (HD) have no proven survival benefit. <b><i>Methods:</i></b> We studied differences among HD auto-HCT whose recurrences were detected on clinical history and exam, versus those routine surveillance scan. <b><i>Results:</i></b> Among the 98 that underwent from 2000 to 2014 at our...